Hepatitis C virus (HCV) remains one of the most significant occupational hazards facing surgeons today, despite its relative invisibility in public discourse compared to HIV. With an estimated 170 million people infected globally—five times more than those affected by HIV—the burden of HCV is substantial. In Canada, approximately 1% of the population carries the virus, with higher prevalence among intravenous drug users, immigrants, and individuals with hemophilia. Crucially, many cases remain asymptomatic, making detection difficult without targeted screening. This silent nature of infection poses a unique challenge in surgical settings where exposure risks are inherent.
Surgeons, particularly orthopedic surgeons, face a heightened risk due to frequent contact with sharp instruments such as drills, saws, and wires, as well as exposure to aerosolized blood and bone fragments during procedures. While double gloving and other protective measures reduce but do not eliminate risk, the true danger lies in the operating field itself. The transmission rate of HCV from an infected patient to a healthcare worker is significantly higher than that of HIV—up to 2% versus 0.3%—and this risk is often underestimated or ignored. Even minor skin punctures can lead to chronic infection, which may progress silently over decades to cirrhosis, liver failure, or hepatocellular carcinoma.
Despite these facts, comprehensive post-exposure protocols remain underdeveloped. A robust response must include immediate serological testing for anti-HCV antibodies following exposure, followed by a qualitative HCV RNA test at 6–8 weeks to confirm acute infection. Early diagnosis is critical, as antiviral therapy initiated within 12 weeks of infection offers the best chance for sustained virologic response.Doxycycline hyclate MedChemExpress Current treatment regimens involve pegylated interferon and ribavirin, lasting 24 to 48 weeks depending on viral genotype.2,6-Diethylaniline Biological Activity However, success rates vary widely—particularly for genotype 1, which accounts for 70% of cases in Canada—and can fall as low as 40%, influenced by age, viral load, and treatment delay.PMID:34929594
Infected physicians are subject to practice restrictions imposed by medical colleges and hospital boards, limiting them to low-risk procedures such as minor soft tissue surgery or endoscopy. These restrictions persist until sustained virologic response is confirmed—typically three to six months after treatment. For many surgeons, especially those mid-career, such limitations represent a profound professional and personal disruption. Unfortunately, support systems are minimal: insurers often deny coverage, and hepatitis C is not universally recognized as an occupational illness, unlike HIV and hepatitis B.
Evidence suggests that HCV exposure among surgeons may be more common than acknowledged. A CDC-sponsored anonymous survey of 3,262 orthopedic surgeons with no nonoccupational risk factors found a 0.8% prevalence of detectable virus, rising to 1.6% with years in practice. These figures imply a hidden cohort of infected surgeons who may unknowingly pose a risk to patients—a risk that remains poorly quantified due to asymptomatic disease.
Given the potential for transmission and the long-term health implications, regular screening for high-risk surgical specialties should be seriously considered. Any such policy must be balanced with ethical safeguards, confidentiality, and access to care. Ultimately, every surgeon must remain vigilant, advocate for clear institutional protocols, and prepare for the possibility of exposure—not out of fear, but out of responsibility to patients and colleagues alike.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com